SLActive

SLActive significantly accelerates the osseointegration process and delivers everything you expect from a successful and patient-friendly implant treatment. Safer and faster treatment in 3-4 weeks for all indications. Reduced healing times from 6-8 weeks down to 3-4 weeks. Increased treatment predictability in crical protocols.

Most implant failures occur in the critical early period between week 2 and 13. Although similar healing patterns were observed for both SLA and SLActive Implants, bone-to-implanta contact (BIC) was greater after 2 weeks and significantly greater after 4 weeks for SLActive Straumann surface features the scientifically proven SLA surface topography. Additionally, it exhibits the surface properties of hydrophilicity and chemical activity, which can significantly accelerate the entire osseointegration process, under the appropriate clinical circumstances.

Hydrophiliticy: The hydrophilic properties of SLActive enable a larger accessible surface area for increased blood contact and bone cell attachment. The chemical activity of SLActive provides ideal conditions for direct protein adsorption, promoting faster osseointegration in comparison to SLA.

Straumann SLA: The SLA surface is produced using a large grit sandblasting technique that generates a macro-roughness on the titanium surface. Following an acid-etching technique superimposes a micro-roughness on the titanium surface. The resulting topography offers the ideal structure for cell attachment and is the basis for the further developed SLActive surface.

Straumann SLActive-surface innovation
• Proven SLA surface topography
• Hydrophilicity for larger accessible surface area
• Chemical activity promoting faster osseointegration